-transparent.png){kind=logo}
Pathologic reviews and clinical studies demonstrate that groups with increased cancer risk can be identified. It is estimated that about 3.5 per cent of colorectal cancers in this country are the result of known heritable cancer syndromes, such as familial polyposis. Much effort is currently being devoted to evaluation of biologic markers, such as cell surface antigens and their antibodies, ornithine decarboxylase, errors in DNA repair, abnormalities in metabolism of polyadenosine diphosphate, and application of molecular genetic techniques to identify patients with genetic cancer susceptibility.
Related Publications
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
March 1998,
The American journal of managed care,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
October 2000,
Seminars in oncology,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
October 1999,
Seminars in oncology,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
June 2000,
Gastrointestinal endoscopy,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
April 2024,
Intestinal research,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
January 2006,
Surgical oncology clinics of North America,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
January 2015,
American family physician,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
June 1995,
Australian and New Zealand journal of medicine,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
July 2005,
Gastrointestinal endoscopy clinics of North America,
J L Kinzie, and
A L Silverman, and
T P Gupta, and
R R Peleman
August 2021,
Diseases of the colon and rectum,
